肝性脑病的发生机制有多种理论学说 ,对其认识不断加深 ,但尚未完全阐明 ,已有研究证实肝病患者血浆阿片肽含量升高 ,且升高水平与肝功能损伤程度一致[1] 。关于阿片肽在肝性脑病中的变化规律尚无系统研究。我们对 5 3例肝性脑病患者血浆β 内啡肽浓度进行了检测 ,并对纳络酮治 The mechanism of hepatic encephalopathy has a variety of theoretical doctrine, to deepen their understanding, but not yet fully elucidated, studies have confirmed that patients with liver disease plasma opioid peptide levels, and elevated levels consistent with the degree of liver damage [1]. Opioid peptide in hepatic encephalopathy in the law of change is not yet systematically studied. We tested 53 patients with hepatic encephalopathy plasma beta endorphin concentrations, and naloxone treatment